Skip to main content

Advertisement

SpringerLink
Log in

Retinal vein occlusion: evaluation of “classic” and “emerging” risk factors and treatment

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Retinal vein occlusion (RVO) is the second most common retinal vein disease and an important cause of blindness and visual morbidity. Systemic risk factors are commonly associated with RVO, while unclear it is the role of the thrombophilic and coagulation disorders. To evaluate “classic” and “emerging” risk factors, and to establish a good treatment for RVO. Fifty patients, 31 males and 19 females, with RVO were selected for our study. RVO patients were divided into two groups: those with central retinal vein occlusion (CRVO) and those with branch retinal vein occlusion (BRVO). All patients were subjected to an anamnestic investigation and were tested for thrombophilia, coagulation disorders and hyperlipidemia. Treatment and prophylaxis were evaluated. We have named “classic” the systemic risk factors associated with RVO and “emerging” those risk factors, haemostasis related, not clearly associated with RVO. RVO occurs more commonly in patients aged over 50. “Emerging” risk factors were more frequent in CRVO, “classic” in BRVO. Hyperhomocysteinemia is the most common “emerging” risk factor related to RVO. 71.4% of tested patients had hypercholesterolemia. Treatment with LMWH would appear to be safe and effective, but the small number of patients considered not allow us a definitive evaluation of its efficacy. Although our study has shown the correlation between RVO and the “emerging” risk factors, more studies are necessary to better know the real role of thrombophilic and coagulation disorders in this disease and to determine a specific protocol for the treatment and prophylaxis of RVO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yau JWH, Lee P, Wong TY, Best J, Jenkins A (2008) Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Inter Med J 38:904–910

    Article  CAS  Google Scholar 

  2. Hayreh SS, Zimmerman MG, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117:429–441

    CAS  PubMed  Google Scholar 

  3. Hayreh SS, Zimmermann B, McCarthy MJ, Podhajsky P (2001) Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131:61–67

    Article  CAS  PubMed  Google Scholar 

  4. Prisco D, Marcucci R (2002) Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophisiol Haemost Thromb 32:308–311

    Article  Google Scholar 

  5. Recchia FM, Carvalho-Recchia CA, Hassan TS (2004) Clinical course of younger patients with central retinal vein occlusion. Arch Ophthalmol 122:317–321

    Article  PubMed  Google Scholar 

  6. Williamson TH (1997) Central retinal vein occlusion: what’s the story? Br J Ophthalmol 81:698–704

    Article  CAS  PubMed  Google Scholar 

  7. Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N (2005) Association of thrombophilia, hypofibrinolysis and retinal vein occlusion. Clin Appl Thromb Haemost 11:375–389

    Article  CAS  Google Scholar 

  8. Kuhli C, Scharrer I, Koch F, Ohrloff C, Hattenbach L (2004) Factor XII deficiency: a thrombophilic risk factor of retinal vein occlusion. Am J Ophthalmol 137:459–464

    Article  CAS  PubMed  Google Scholar 

  9. Marcucci R, Giusti B, Betti I, Evangelisti L, Fedi S, Sodi A, Cappelli S, Menchini U, Abbate R, Prisco D (2003) Genetics determinants of fasting and post-methionine hiperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 110:7–12

    Article  CAS  PubMed  Google Scholar 

  10. Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F, Mammi C, Occhiuto A, Trapani Lombardo V (2007) Role of hyperomocysteinemia in retinal vascular occlusive disease. Clin Appl Thromb Haemost 13:104–107

    Article  Google Scholar 

  11. Janssen MCH, den Heijer M, Cruysberg JRM, Wollersheim H, Bredie SJH (2005) Retinal vein occlusion: a form of venous Thrombosis or a complication of atherosclerosis? Thromb Haemost 93:1021–1026

    CAS  PubMed  Google Scholar 

  12. Weger M, Renner W, Steinbrugger I, Cichoki L, Temmel W, Stanger O, El-Shabrawi Y, Lechner H, Schmut O, Haas A (2005) Role of thrombophilic gene polymorfism in branch retinal vein occlusion. Ophthalmology 112:1910–1915

    Article  PubMed  Google Scholar 

  13. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342(10):696–701

    Article  CAS  PubMed  Google Scholar 

  14. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S (2004) The risk of recurrent thromboembolism in men and women. N Engl J Med 350(25):2558–2563

    Article  CAS  PubMed  Google Scholar 

  15. Glueck CJ, Wang P, Hutchins R, Petersen, Golnik K, 3 (2008) Ocular vascular thrombotic events: central retinal vein occlusion and central retinal artery occlusion. Clin Appl Thromb Hemost 14(3):286–294

    Article  PubMed  Google Scholar 

  16. Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, D Prisco (2001) Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 86:772–776

    CAS  PubMed  Google Scholar 

  17. Cahill MT, Stinnett SS, Fekrat S (2003) Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and Thermolabile MTHFR genoype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 136:1136–1150

    Article  CAS  PubMed  Google Scholar 

  18. Chua B, Kifley A, Wong TY, Mitchell P (2005) Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 139:181–182

    Article  CAS  PubMed  Google Scholar 

  19. Coniglio M, Platania A, Di Nucci GD, Arcieri P, Modzrewska R, Mariani G (1996) Antiphospholipid-protein antibodies are not an uncommon feature in retinal vein occlusions. Thromb Res 83:183–188

    Article  CAS  PubMed  Google Scholar 

  20. Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P, Stroop D, Gruppo R (1999) Heritable thrombophilia and hypofibrinolysis. Arch Ophthal 1117:43–49

    Google Scholar 

  21. Bandello F, Viganò D’Angelo S, Parlavecchia M, Tavola A, Della Valle P, Brancato R, D’Angelo A (1994) Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 72:39–43

    CAS  PubMed  Google Scholar 

  22. Tsantes AE, Nikolopulos GK, Bagos PG, Bonavas S, Kopterides P, Vaiopoulos G (2008) The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thromb Res 122(6):736–742

    Article  CAS  PubMed  Google Scholar 

  23. Gori AM, Marcucci R, Fatini C, Gensini F, Sticchi E, Sodi A, Cappelli S, Menchini U, Gensini GF, Abbate R, Prisco D (2004) Impaired fibrinolysis in retinal vein occlusion: a role of genetics determinants of PAI-1 levels. Thromb Haemost 92:54–60

    CAS  PubMed  Google Scholar 

  24. Ay C, Bencur P, Vormittag R, Sailer T, Jungbauer C, Vukovich T, Mannhalter C, Pabinger I (2007) The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Thromb Haemost 98(4):777–782

    CAS  PubMed  Google Scholar 

  25. Larsson J, Olafsdottir E, Bauer B (1996) Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 80:200–202

    Article  CAS  PubMed  Google Scholar 

  26. Scat Y, Morin Y, Morel C et al (1995) Retinal vein occlusion and resistance to activated protein C. J Fr Ophthalmol 18:758–762

    CAS  Google Scholar 

  27. Williamson TH, Rumley A, Lowe GD (1996) Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: a population-controlled study. Br J Ophtalmol 80:203–208

    Article  CAS  Google Scholar 

  28. Graham SL, Goldbberg I, Murray B, Beaumont P, Chong BH (1996) Activated protein C resistance: low incidence in glaucomatous disk hemorrage and central retinal vein occlusion. Aust N Z J Ophthalmol 24:199–205

    Article  CAS  PubMed  Google Scholar 

  29. Gottlieb JL, BliceJ P, Mestichelli B, Konkle BA, Benson WE (1998) Activated protein C resistance, Factor V Leiden and central retinal vein occlusion in young adults. Arch Ophthalmol 116:577–579

    CAS  PubMed  Google Scholar 

  30. Marcucci R, Bertini L, Alessandriello Liotta A, Rogolino A, Antonucci E, Ilari I, Pepe G, Prisco D (2000) Activated protein C resistance is a risk factor for central retinal vein occlusion. Ann Ital Med Int 15:195–198

    CAS  PubMed  Google Scholar 

  31. Albisinni R, Coppola A, Loffredo M, Cerbone AM, Di Minno G, Greco GM (1998) Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost 80:702–703

    CAS  PubMed  Google Scholar 

  32. Prisco D, Marcucci R, Bertini L, Gori AM (2002) Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Int Med 13:163–169

    Article  Google Scholar 

  33. Prisco D, Bertini L, Marcucci R, Poli D (2000) Le occlusioni venose retiniche: malattie internistiche? Ann Ital Med Int 15:75–84

    CAS  PubMed  Google Scholar 

  34. Leoncini G, Bruzzese D, Signorello MG, Armani U, Piana A, Ghiglione D, Camicione P (2007) Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost 97:218–277

    CAS  PubMed  Google Scholar 

  35. Meschengieser SS (2005) Retinal vein occlusion: a venous complication in an “arterial” patient? Thromb Haemost 93:1013

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Hemorrhagic and Thrombotic Diseases, General University Hospital of Udine, Udine, Italy

    Marina Turello, Samantha Pasca, Roberto Daminato, Patrizia Dello Russo, Ugo Venturelli & Giovanni Barillari

  2. Clinical Analysis Laboratory, General University Hospital of Udine, Udine, Italy

    Roberta Giacomello

Authors
  1. Marina Turello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samantha Pasca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto Daminato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrizia Dello Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberta Giacomello
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ugo Venturelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giovanni Barillari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samantha Pasca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turello, M., Pasca, S., Daminato, R. et al. Retinal vein occlusion: evaluation of “classic” and “emerging” risk factors and treatment. J Thromb Thrombolysis 29, 459–464 (2010). https://doi.org/10.1007/s11239-009-0384-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-009-0384-5

Keywords

Search

Navigation